SkyQuest Technology Group recently introduced Biobanking Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Biobanking Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Biobanking Market size was valued at USD 72.0 billion in 2023 and is poised to grow from USD 76.9 billion in 2024 to USD 130.16 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).
Biobanking has grown tremendously over the years and is currently gaining momentum. The combination of advanced technology, data analytics and automation has transformed traditional biobanks into virtual biobanks, creating transformational Biobanking Market potential. Globally, there are many types of biobanks such as, disease-related biobanks, human-based biobanks quantitatively, tissue banks, blood banks which support the market. The spreading degenerative diseases are benefiting immensely from the growth of this market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/biobanking-market
The Biobanking Market has grown rapidly in recent years. The integration of advanced technologies into the biobanking process is the main driver for the market. Virtual biobanking is now transforming the biobanking process because it reduces processing time and enables researchers to conduct research more efficiently. Virtual biobanking has helped biobanks generate more revenue, thereby increasing market value and driving Biobanking Market growth. In addition, many software companies are undertaking software developments to facilitate the biobanking process and the adoption of virtual biobanking systems.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Biobanking Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Product & Service
Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment), Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables), Services (Storage Services, Processing Services, Transport Services, Supply Services), Software
Biobanks Type
Physical/Real Biobanks, Tissue Biobanks, Population Based Biobanks, Genetic (DNA/RNA), Disease Based Biobanks, Virtual Biobanks
Sample Type
Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products
Storage Type
Manual Storage, Automated Storage
Ownership
Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations
Application
Regenerative Medicine, Life Science Research, Clinical Research
End user
Pharmaceutical, Biotechnology Companies and CROs, Academic, Research Institutes, Hospitals
Biobanking Market – Regional Analysis:
– Biobanking North America Market includes (Canada, Mexico, USA)
– Biobanking Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Biobanking Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Biobanking South America Market includes (Brazil, Argentina)
– Biobanking Oceania Market (Australia & New Zealand)
Top Market Players in Biobanking Market are:
Thermo Fisher Scientific Inc. (United States)
Merck KGaA (Germany)
QIAGEN N.V. (Netherlands)
Hamilton Company (United States)
Tecan Trading AG (Switzerland)
Becton, Dickinson and Company (BD) (United States)
Lonza Group AG (Switzerland)
Charles River Laboratories International, Inc. (United States)
BioLife Solutions, Inc. (United States)
Brooks Automation, Inc. (United States)
Greiner Bio-One International GmbH (Austria)
STEMCELL Technologies Inc. (Canada)
Chart Industries, Inc. (United States)
BioIVT (United States)
Firalis S.A. (France)
Celltex Therapeutics Corporation (United States)
Sigma-Aldrich Corporation (United States)
Hope Biosciences (United States)
54Gene (Nigeria)
Biobanking Key Market Trends:
Integrating Artificial Intelligence (AI) and Big Data Analytics: One of the most important trends in the biobanking market is the integration of artificial intelligence (AI) and big data analytics. This technology helps biobanks optimize specimen tracking, improve data management, and improve the quality of specimen storage. AI-driven analytics enable researchers to identify patterns and insights from large biosample datasets, facilitating the discovery of the new biomarkers and accelerating drug development processes.
Collaboration and Standards: Another trend shaping the biobanking market is the increasing emphasis on globalization and standardization. As biobanks around the world collaborate on research projects, the need for standardized protocols in biosample collection, storage and data sharing is increasing. initiatives are paying attention to creating universal biobanking standards to ensure sample quality and reliability, creating a more efficient and connected research ecosystem.
Also Read –
https://pando.life/article/376474
http://prsync.com/skyquest-technology-consulting-pvt-ltd/natural-gas-storage-market–expanding-infrastructure-for-energy-security-4667001/
Forward-Looking Insights
The Biobanking Market is set to experience sustained growth, fueled by technological advancements, broader market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
